Focus Financial Network Inc. Has $504,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Focus Financial Network Inc. reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,856 shares of the company’s stock after selling 445 shares during the quarter. Focus Financial Network Inc.’s holdings in Colgate-Palmolive were worth $504,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive during the second quarter worth approximately $25,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at about $42,000. Gradient Investments LLC increased its position in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after acquiring an additional 400 shares in the last quarter. Finally, Financial Connections Group Inc. acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $68,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CL shares. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target for the company. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. UBS Group lifted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. Finally, Morgan Stanley raised their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average price target of $105.11.

Colgate-Palmolive Stock Performance

NYSE CL opened at $93.33 on Friday. The firm has a market cap of $76.25 billion, a P/E ratio of 26.74, a price-to-earnings-growth ratio of 3.38 and a beta of 0.40. The company has a quick ratio of 0.28, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s 50 day moving average is $102.26 and its 200-day moving average is $98.27. Colgate-Palmolive has a 12-month low of $74.22 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. Colgate-Palmolive’s payout ratio is 57.31%.

Insiders Place Their Bets

In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 over the last 90 days. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.